SEC Puts Impath Fraud To Rest With $2M Settlement
The former chief executive of Impath Inc., an insolvent cancer-testing company, agreed Tuesday to pay $2 million to settle civil charges brought by securities regulators, adding to the three-month prison term...To view the full article, register now.
Already a subscriber? Click here to view full article